Feng Shao

264 Guangzhou Road, 
Nanjing, CN 
264 Guangzhou Road, 
Nanjing, CN 
OverviewLocationsClinical Research

Overview

Feng Shao practices in Nanjing, China. His top areas of expertise are Cholangiocarcinoma (Bile Duct Cancer), Lung Cancer, Pulmonary Sequestration, Endoscopy, and Stent Placement.

His clinical research consists of co-authoring 179 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

264 Guangzhou Road, Nanjing, 210029, China
Other Locations
State Key Laboratory Of Materials Oriented Chemical Engineering, Nanjing, 211816, China
No. 1 Banshan East Road, Hangzhou, 310022, China
60 West Wuning Road, Dongyang, 322100, China
60 Wu Ning Xi Road, Dongyang, 322100, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

An Open-Label, Non-Randomized, Single-Center Study to Determine the Absorption, Metabolism and Excretion of A Single Dose [14C] AC0010 in Patients With Advanced NSCLC
An Open-Label, Non-Randomized, Single-Center Study to Determine the Absorption, Metabolism and Excretion of A Single Dose [14C] AC0010 in Patients With Advanced NSCLC
Enrollment Status: Completed
Publish Date: October 03, 2017
Intervention Type: Drug
Study Phase: Phase 1

179 Total Publications

Physiologically Based Pharmacokinetic Modeling to Evaluate Drug-Drug Interactions of Tacrolimus With Ritonavir, a CYP3A Irreversible Inhibitor: Applications for Dosing Optimization in Transplant Patients.
Physiologically Based Pharmacokinetic Modeling to Evaluate Drug-Drug Interactions of Tacrolimus With Ritonavir, a CYP3A Irreversible Inhibitor: Applications for Dosing Optimization in Transplant Patients.
Journal: Clinical pharmacology in drug development
Published: April 14, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Shao's expertise for a condition
ConditionClose
        View All 26 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile